Pages that link to "Q52580579"
Jump to navigation
Jump to search
The following pages link to Efficacy and safety of biosimilar insulins compared to their reference products: A systematic review. (Q52580579):
Displaying 4 items.
- Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia (Q91959107) (← links)
- Lilly Insulin Glargine Versus Lantus® in Type 2 Diabetes Mellitus Patients: India and East Asia Subpopulation Analyses of the ELEMENT 5 Study (Q92233754) (← links)
- An Efficient Development Paradigm for Biosimilars (Q92466215) (← links)
- A Propensity Score Matched Comparison of Brand and Biosimilar Basal Insulin in Non-Critical Hospitalized Patients with Type 2 Diabetes Mellitus (Q92545492) (← links)